99% Savings - Buy Just @1 Rs X
Zipod CV 50 Mg/31.25 Mg Dry Syrup is a prescription drug, available for use as Syrup. Secondary and off-label uses of Zipod CV 50 Mg/31.25 Mg Dry Syrup have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Zipod CV 50 Mg/31.25 Mg Dry Syrup. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Zipod CV 50 Mg/31.25 Mg Dry Syrup as well, which are listed below. Usually, these side effects of Zipod CV 50 Mg/31.25 Mg Dry Syrup go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Zipod CV 50 Mg/31.25 Mg Dry Syrup has a Mild effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Zipod CV 50 Mg/31.25 Mg Dry Syrup has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zipod CV 50 Mg/31.25 Mg Dry Syrup related warnings section.
Zipod CV 50 Mg/31.25 Mg Dry Syrup is not recommended if you suffer from certain medical conditions as it can have adverse effects. Jaundice are examples of such conditions. Other conditions have been mentioned below in the Zipod CV 50 Mg/31.25 Mg Dry Syrup contraindications section.
Additionally, Zipod CV 50 Mg/31.25 Mg Dry Syrup may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Zipod CV 50 Mg/31.25 Mg Dry Syrup is safe while driving, and is addiction.
Zipod CV 50 Mg/31.25 Mg Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Zipod CV 50 Mg/31.25 Mg Dry Syrup safe for pregnant women?
Zipod Cv rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Zipod CV 50 Mg/31.25 Mg Dry Syrup safe during breastfeeding?
Zipod Cv can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Zipod CV 50 Mg/31.25 Mg Dry Syrup on the Kidneys?
Zipod Cv may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Zipod CV 50 Mg/31.25 Mg Dry Syrup on the Liver?
The liver can be affected by Zipod Cv. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Zipod Cv only after medical advice.
What is the effect of Zipod CV 50 Mg/31.25 Mg Dry Syrup on the Heart?
Very few cases of side effects of Zipod Cv on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Zipod CV 50 Mg/31.25 Mg Dry Syrup unless your doctor advises you to do so -
Is this Zipod CV 50 Mg/31.25 Mg Dry Syrup habit forming or addictive?
Forming a habit of Zipod CV 50 Mg/31.25 Mg Dry Syrup has not been reported.
Interaction between Food and Zipod CV 50 Mg/31.25 Mg Dry Syrup
Taking Zipod CV 50 Mg/31.25 Mg Dry Syrup with food does not harm your health.
Interaction between Alcohol and Zipod CV 50 Mg/31.25 Mg Dry Syrup
Information about the interaction of Zipod CV 50 Mg/31.25 Mg Dry Syrup and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311